CIK 0001630627
- Accelerated filer
TREACE MEDICAL CONCEPTS, INC.
Sign in to watch- Ticker
- TMCI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- Operating
- EIN
- 471052611
- Phone
- +1 904-373-5940
- Business address
- 100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081
- Open-market buys, last 90 days
- $47,731
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$47,731. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-08 | Lubben Terry W. SVP, Operations | Purchase | +2,500 | $18.62 | $47K | 5,850 |
| 2022-03-08 | Lubben Terry W. SVP, Operations | Grant or award · Stock Option (Right to Buy) | +25,800 | 25,800 | ||
| 2022-03-08 | Treace John T. Chief Executive Officer | Grant or award | +33,875 | 5,456,455 | ||
| 2022-03-08 | Treace John T. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +240,566 | 240,566 | ||
| 2022-03-08 | Treace John T. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +20,884 | 20,884 | ||
| 2022-03-08 | Hair Mark Chief Financial Officer | Grant or award | +11,950 | 21,950 | ||
| 2022-03-08 | Hair Mark Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +92,100 | 92,100 | ||
| 2022-03-08 | Frias Jaime A. Chief Legal Officer | Grant or award | +7,875 | 50,659 | ||
| 2022-03-08 | Frias Jaime A. Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +60,800 | 60,800 | ||
| 2022-03-08 | Berutti Aaron SVP, Sales | Grant or award | +11,950 | 11,950 | ||
| 2022-03-08 | Berutti Aaron SVP, Sales | Grant or award · Stock Option (Right to Buy) | +92,100 | 92,100 | ||
| 2022-03-02 | Scanlan Sean F. SVP, Marketing | Exercise or conversion | +25,000 | $1.05 | $26K | 25,000 |
| 2022-03-02 | Scanlan Sean F. SVP, Marketing | Sale | −25,000 | $20.82 | $521K | 0 |
| 2022-03-02 | Scanlan Sean F. SVP, Marketing | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 124,149 | ||
| 2022-02-09 | Scanlan Sean F. SVP, Marketing | Exercise or conversion | +3,873 | $1.05 | $4K | 3,873 |
| 2022-02-09 | Scanlan Sean F. SVP, Marketing | Sale | −3,873 | $20.16 | $78K | 0 |
| 2022-02-09 | Scanlan Sean F. SVP, Marketing | Exercise or conversion · Stock Option (Right to Buy) | −3,873 | 149,149 | ||
| 2022-02-08 | Scanlan Sean F. SVP, Marketing | Exercise or conversion | +21,127 | $1.05 | $22K | 21,127 |
| 2022-02-08 | Scanlan Sean F. SVP, Marketing | Sale | −21,127 | $20.02 | $423K | 0 |
| 2022-02-08 | Scanlan Sean F. SVP, Marketing | Exercise or conversion · Stock Option (Right to Buy) | −21,127 | 153,022 |
Page 21 of 28 · 560 trades